David B. Elsbree - Sep 15, 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Director
Signature
/s/ John Sprague, Attorney-in-Fact
Stock symbol
TTOO
Transactions as of
Sep 15, 2023
Transactions value $
$0
Form type
4
Date filed
10/11/2023, 05:00 PM
Previous filing
Oct 13, 2022
Next filing
Sep 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +2.3K +41.64% 7.82K Sep 15, 2023 Direct F1
holding TTOO Common Stock 200 Sep 15, 2023 By spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -2.3K -100% $0.00* 0 Sep 15, 2023 Common Stock 2.3K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.